How does the USPTO handle restriction requirements for nucleotide sequences in national applications?
For national applications filed under 35 U.S.C. 111(a), the USPTO handles restriction requirements for nucleotide sequences according to the standards in MPEP Chapter 800. As stated in MPEP 803.04: “For national applications filed under 35 U.S.C. 111(a), polynucleotide inventions will be considered for restriction, rejoinder, and examination practice in accordance with the standards set forth…
Read More